about
Regulation of heme oxygenase 1 expression by miR-27b with stem cell therapy for liver regeneration in ratsHemodynamics of portal venous stenosis before and after treatment in pediatric liver transplantation: evaluation with Doppler ultrasound.Interventional radiology in living donor liver transplantDiagnostic pitfall of sebaceous gland metaplasia of the esophagus.Adaptor protein Shc acts as an immune-regulator for the LPS-stimulated maturation of bone marrow-derived dendritic cellsImmunological and regenerative aspects of hepatic mast cells in liver allograft rejection and tolerance.Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome.Pyrosequencing to identify homogeneous phenomenon when using recipients/donors with different CYP3A5*3 genotypes in living donor liver transplantation.Impact of pre-operative transarterial embolization on the treatment of hepatocellular carcinoma with liver transplantation.Endoscopic biopsy as quality assurance for endoscopic services.High pressure air jet in the endoscopic preparation room: risk of noise exposure on occupational health.Repeated-measures implication of hepatocellular carcinoma biomarkers in living donor liver transplantation.Cytochrome P450 in living donor liver transplantation.Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal StudyAssociation of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation.Effect of autologous blood donation on the central venous pressure, blood loss and blood transfusion during living donor left hepatectomy.Upper gastrointestinal carcinoid tumors incidentally found by endoscopic examinations.MicroRNA-27b Enhances the Hepatic Regenerative Properties of Adipose-Derived Mesenchymal Stem CellsClinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy.Induction of antinuclear antibodies by de novo autoimmune hepatitis regulates alloimmune responses in rat liver transplantation.Section 1. Image evaluation of fatty liver in living donor liver transplantation.High-level disinfection of gastrointestinal endoscope reprocessing.Living donor liver transplantation: the Asian perspective.Hepatic miR-301a as a Liver Transplant Rejection Biomarker? And Its Role for Interleukin-6 Production in Hepatocytes.The effect of exogenous histone H1 on rat adipose-derived stem cell proliferation, migration, and osteogenic differentiation in vitro.Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.Short report: Abnormal liver function in scrub typhus.Liver abscess complicating transcatheter arterial embolization: a rare but serious complication. A retrospective study after 3878 procedures.Molecular Identification of Biliary Isospora Belli: A Case Report.Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.Novel low-cost endoscopic cap for esophageal foreign objects: a case report.Section 14. Combination of entecavir plus low-dose on-demand hepatitis B immunoglobulin is effective with very low hepatitis B recurrence after liver transplantation.Section 13. Short-course pretransplant antiviral therapy is a feasible and effective strategy to prevent hepatitis C recurrence after liver transplantation in genotype 2 patients.Comparing the efficacy and clinical outcome of telbivudine and entecavir naïve patients with hepatitis B virus-related compensated cirrhosis.Dextrose in the banked blood products does not seem to affect the blood glucose levels in patients undergoing liver transplantation.Risk factors for intraoperative portal vein thrombosis in pediatric living donor liver transplantation.Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.The prevalence and prognostic significance of spontaneous bacterial peritonitis in severe acute hepatitis with ascites.A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study.Recurrent gastric varices bleeding after living-related liver transplantation successfully eradicated by splenic artery embolization.
P50
Q28567084-79D4C353-1AC1-41A1-BC2E-03648C3D8CEAQ33400206-0DE4F223-8864-4537-B3A8-AFFA682FEEA3Q33661144-A42A3D23-D6E6-4745-BBE6-44C203DEBC57Q33898273-E64A8FAA-4920-4108-818B-3C57575E2E87Q33911684-AFD2CFE9-7781-415D-B465-2C28DAE6E9EBQ34277866-0AA01086-11C9-4AFA-B479-D6963EA815F0Q34340594-F4140F1E-A8C0-461F-BA61-CC48C96ADB65Q34949176-8A6F883B-30DA-4254-8EB3-E4BB063D1E49Q35010399-23AF300F-8628-46CE-BA61-5C6295826588Q35050318-A82A7237-8C59-4A6B-9512-CD48D6D94ACAQ35091665-E234664C-8286-4FCD-9963-242882C240AEQ35610736-37507A7E-A7D6-4C93-926E-BE7D534F75C7Q35632041-64C7CC2A-D068-40E8-B07E-D7D4F8463C52Q35952819-7F88EEB5-118D-44CD-B70F-AF319D5DA838Q36044806-D1722F85-61A5-44EE-BFCA-E5D0A4911AF6Q36190510-B72605FA-9526-4774-94CC-F9FFC461563CQ36474518-1EB08042-3BCF-492D-A6B1-823565A04426Q36946187-E21DDD89-1CE3-46F3-B6C2-C17A1C6C7E30Q37279232-EF374A5C-5440-40DF-AE65-E0B64EC916ABQ37457064-FA221C7F-C3B9-4A55-BB5E-7CDC2EEA9F58Q38213605-A5B2FE80-E749-4843-A68F-0CB6B02BC776Q38362680-01A0D865-FF0A-4F13-832B-877F8344D5D2Q38438031-BE8915DA-BB6A-4B23-A59B-E45397803791Q38748940-799B86B1-7996-4193-B9A3-21ACD0686410Q39667226-46DB8D88-AA67-4997-9AE2-8359D8B304CAQ40098532-3E718514-BEAD-4DA8-A09D-64B5228B340BQ40496497-65F38F17-3706-4B9C-A54C-517ADD31BA29Q40529767-C57804D0-064D-4D12-AEB1-C18C3CC49BF3Q40760754-2402058D-DA19-4764-BC03-F4ADE9457FA0Q41685562-DB439815-B629-4345-8D3B-E05CAED9588FQ42096954-3F251C49-950D-41BC-89B4-E03B4DD581DBQ42217341-5D0E6D7C-B9F6-4A62-B5E4-793753227CD0Q42217344-65BBC77C-61D9-44A6-89A7-3C13D84AD51DQ42225934-9F391EC8-9E46-4759-8DD1-6D95E2E81E8DQ42712394-81088D9B-B0A6-47C6-848D-22D2B7CFBAF2Q43949204-56462BC0-AAA1-4008-9BBB-BB655A71889DQ44220301-559380A3-8F79-4B9F-8D41-74D261F55569Q44638380-CF720F30-9696-4A17-A3F8-9E3A562675D0Q45100727-128DE92B-6A54-4D14-94C6-79CF2565A80DQ45226188-28269E54-6F14-4A53-970A-49880F58F781
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
King-Wah Chiu
@ast
King-Wah Chiu
@en
King-Wah Chiu
@es
King-Wah Chiu
@sl
type
label
King-Wah Chiu
@ast
King-Wah Chiu
@en
King-Wah Chiu
@es
King-Wah Chiu
@sl
prefLabel
King-Wah Chiu
@ast
King-Wah Chiu
@en
King-Wah Chiu
@es
King-Wah Chiu
@sl
P106
P1153
7202988099
P31
P3835
king-wah-chiu
P496
0000-0003-2108-6539